SunBird Bio
MergedCambridge, United States · Founded 2021 · $108.2M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- sunbirdbio.com
- Total Funding
- $108.2M
- Last Round
- $85.0M Series BOct 2024
- Rounds
- 2
About
SunBird Bio is a biotechnology company developing proprietary protein-based blood diagnostic tests to enable earlier and more accurate diagnosis and monitoring of Alzheimer's disease, Parkinson's disease, and other neurological disorders. The company's platform provides unprecedented protein-level insights from simple blood draws, supporting both clinical diagnosis and treatment monitoring.
Summary
SunBird Bio is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $108.2M in total across 2 rounds, most recently a $85.0M Series B round in Oct 2024. Investors include Deerfield Management, Casdin Capital and ARCH Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...